<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03962634</url>
  </required_header>
  <id_info>
    <org_study_id>HM20014136 - pediatric</org_study_id>
    <nct_id>NCT03962634</nct_id>
  </id_info>
  <brief_title>Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric</brief_title>
  <official_title>Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary goal of the study is to compare the success rates of pulpal anesthesia (defined&#xD;
      as ability to complete the intended dental procedure without the need for rescue anesthesia)&#xD;
      between Kovanaze nasal mist and Articaine needle anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In June 2016, an intranasal delivery system of local anesthesia called Kovanaze, gained FDA&#xD;
      approval. [9] Kovanaze is available as a 0.2 ml metered spray and is intended to achieve&#xD;
      pulpal anesthesia of 5 maxillary teeth on either side of the face. Even though success rates&#xD;
      between 83 and 90 % have been reported for adults and children &gt;40kg, [10] FDA label (Section&#xD;
      14.2) provides data for children (&gt;10 kg) indicating that the drug is safe for use in&#xD;
      children as long as the dose is adjusted to bodyweight of the child. [9]&#xD;
&#xD;
        -  One 0.1 mL spray for patients weighing 10 kg to less than 20 kg;&#xD;
&#xD;
        -  Two 0.1 mL sprays for 20 kg to less than 40 kg; or&#xD;
&#xD;
        -  Two 0.2 mL sprays for patients weighing 40 kg or more.&#xD;
&#xD;
      With the ability to avoid the traditional painful injection Kovanaze offers promise in the&#xD;
      field of maxillary anesthesia and this study intends to:&#xD;
&#xD;
        1. Compare Kovanaze to conventional needle anesthetic children (at least 6 years of age and&#xD;
           weighing &gt; 20 kg)&#xD;
&#xD;
        2. Evaluate patient anxiety, tolerance and acceptability of Kovanaze in patients undergoing&#xD;
           dental procedures&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Drug is no longer being manufactured&#xD;
  </why_stopped>
  <start_date type="Actual">August 28, 2019</start_date>
  <completion_date type="Actual">September 17, 2019</completion_date>
  <primary_completion_date type="Actual">September 17, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success Rate of Pupal Anesthesia</measure>
    <time_frame>immediately after dental procedure, an average of 3 hours</time_frame>
    <description>% dental procedures completed without the need for rescue anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spread of Anesthesia</measure>
    <time_frame>immediately after dental procedure, an average of 3 hours</time_frame>
    <description>Number of teeth anesthetized in maxillary arch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Anxiety Level</measure>
    <time_frame>from baseline to immediately after dental procedure</time_frame>
    <description>STAI-Y6 - 6 item youth questionnaire assessing anxiety on a 4 point scale ranging from 1 (Not at all) to 4 (very much). Scores range from 6 to 24.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>immediately after dental procedure, an average of 3 hours</time_frame>
    <description>Venham Behavior rating scale - single item 6 point scale used by provider to rate child's behavior during treatment. Item ranges from 0 (no protest) to 5 (high protest, no cooperation from child)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood Pressure</measure>
    <time_frame>from baseline to immediately after dental procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate</measure>
    <time_frame>from baseline to immediately after dental procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pain</measure>
    <time_frame>from baseline to immediately after dental procedure</time_frame>
    <description>Emoji scale ranging from 1 (very negative face) to 7 (very positive face)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Caries,Dental</condition>
  <condition>Apical Periodontitis</condition>
  <arm_group>
    <arm_group_label>Kovanaze Nasal Spray (Pediatrics)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articaine Injections (Pediatrics)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Kovanaze Nasal Spray</intervention_name>
    <description>Intra-nasal local anesthetic</description>
    <arm_group_label>Kovanaze Nasal Spray (Pediatrics)</arm_group_label>
    <other_name>Tetracaine HCl, Oxymetazoline HCl, NDC # 69803-100-10</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Articaine Injection</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Articaine Injections (Pediatrics)</arm_group_label>
    <other_name>Septocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists Class I or II&#xD;
&#xD;
          -  Preoperative heart rate of 55 to 100 beats per minute&#xD;
&#xD;
          -  Maximum blood pressure reading of 166/100 mmHg&#xD;
&#xD;
          -  Treatment for a pathology in the maxillary anterior tooth or premolar that requires&#xD;
             administering local anesthesia&#xD;
&#xD;
        Additional Pediatric Inclusion Criteria:&#xD;
&#xD;
          -  Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel&#xD;
             crowns in one maxillary tooth&#xD;
&#xD;
        Additional Endodontic Inclusion Criteria:&#xD;
&#xD;
          -  Adults (&gt;18 years) who require non-surgical root canal treatment in maxillary anterior&#xD;
             teeth&#xD;
&#xD;
        Additional General Practice Inclusion Criteria:&#xD;
&#xD;
          -  Adults who require restorations in the maxillary teeth that would need local&#xD;
             anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inadequately controlled thyroid disease&#xD;
&#xD;
          -  Five or more nosebleeds in the past month&#xD;
&#xD;
          -  Known allergy to any study drug or para-aminobenzoic acid&#xD;
&#xD;
          -  History of methemoglobinemia&#xD;
&#xD;
          -  Taking monoamine oxidase inhibitors, tricyclic antidepressants (i.e. amitriptyline),&#xD;
             or non-selective beta adrenergic antagonists (i.e. propranolol);&#xD;
&#xD;
          -  Taking oxymetazoline-containing products (i.e., Afrin) in the last 24 hours.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Parthasarathy Madurantakam, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 21, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2019</study_first_posted>
  <results_first_submitted>October 7, 2020</results_first_submitted>
  <results_first_submitted_qc>November 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 19, 2020</results_first_posted>
  <last_update_submitted>November 13, 2020</last_update_submitted>
  <last_update_submitted_qc>November 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cavities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periapical Periodontitis</mesh_term>
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT03962634/Prot_SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Kovanaze Nasal Spray (Pediatrics)</title>
          <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
        </group>
        <group group_id="P2">
          <title>Articaine Injections (Pediatrics)</title>
          <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
      <group_list>
        <group group_id="B1">
          <title>Kovanaze Nasal Spray (Pediatrics)</title>
          <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
        </group>
        <group group_id="B2">
          <title>Articaine Injections (Pediatrics)</title>
          <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</description>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Success Rate of Pupal Anesthesia</title>
        <description>% dental procedures completed without the need for rescue anesthesia</description>
        <time_frame>immediately after dental procedure, an average of 3 hours</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate of Pupal Anesthesia</title>
          <description>% dental procedures completed without the need for rescue anesthesia</description>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spread of Anesthesia</title>
        <description>Number of teeth anesthetized in maxillary arch</description>
        <time_frame>immediately after dental procedure, an average of 3 hours</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Spread of Anesthesia</title>
          <description>Number of teeth anesthetized in maxillary arch</description>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Anxiety Level</title>
        <description>STAI-Y6 - 6 item youth questionnaire assessing anxiety on a 4 point scale ranging from 1 (Not at all) to 4 (very much). Scores range from 6 to 24.</description>
        <time_frame>from baseline to immediately after dental procedure</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Anxiety Level</title>
          <description>STAI-Y6 - 6 item youth questionnaire assessing anxiety on a 4 point scale ranging from 1 (Not at all) to 4 (very much). Scores range from 6 to 24.</description>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anxiety</title>
        <description>Venham Behavior rating scale - single item 6 point scale used by provider to rate child's behavior during treatment. Item ranges from 0 (no protest) to 5 (high protest, no cooperation from child)</description>
        <time_frame>immediately after dental procedure, an average of 3 hours</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety</title>
          <description>Venham Behavior rating scale - single item 6 point scale used by provider to rate child's behavior during treatment. Item ranges from 0 (no protest) to 5 (high protest, no cooperation from child)</description>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Blood Pressure</title>
        <time_frame>from baseline to immediately after dental procedure</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Blood Pressure</title>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Heart Rate</title>
        <time_frame>from baseline to immediately after dental procedure</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Heart Rate</title>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pain</title>
        <description>Emoji scale ranging from 1 (very negative face) to 7 (very positive face)</description>
        <time_frame>from baseline to immediately after dental procedure</time_frame>
        <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
        <group_list>
          <group group_id="O1">
            <title>Kovanaze Nasal Spray (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Articaine Injections (Pediatrics)</title>
            <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pain</title>
          <description>Emoji scale ranging from 1 (very negative face) to 7 (very positive face)</description>
          <population>Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 3 hours, the length of the dental procedure</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Kovanaze Nasal Spray (Pediatrics)</title>
          <description>Children &gt;20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth&#xD;
Kovanaze Nasal Spray: Intra-nasal local anesthetic</description>
        </group>
        <group group_id="E2">
          <title>Articaine Injections (Pediatrics)</title>
          <description>Children &gt;20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth&#xD;
Articaine Injection: Local anesthetic</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Parthasarathy Madurantakam</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>804-828-4953</phone>
      <email>madurantakap@vcu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

